GI Cancer Consortium
Gastrointestinal Cancers
UnknownActive
Key Facts
About Criterium
Criterium is a long-established, privately-held CRO that has carved out a specialized niche in oncology clinical research through its innovative Oncology Consortia model. The company combines hands-on operational expertise with technology solutions like interactive voice/web response (IVR/IWR) and ePRO to manage complex trials efficiently. Its core strategy involves forming disease-specific consortia with top-tier universities and cancer centers, enabling rapid patient recruitment and high-quality data generation for pharmaceutical and biotech sponsors. While primarily a service provider, its deep integration into therapeutic development gives it significant insight into the oncology pipeline landscape.
View full company profileTherapeutic Areas
Other Gastrointestinal Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| Domvanalimab + Zimberelimab | Taiho Pharma | Phase 3 |